- Home
- XNCR vs IGD Comparison
XNCR vs IGD Comparison
Compare XNCR & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- IGD
- Stock Information
- Founded
- XNCR 1997
- IGD N/A
- Country
- XNCR United States
- IGD United States
- Employees
- XNCR N/A
- IGD N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- IGD Trusts Except Educational Religious and Charitable
- Sector
- XNCR Health Care
- IGD Finance
- Exchange
- XNCR Nasdaq
- IGD Nasdaq
- Market Cap
- XNCR 565.1M
- IGD 456.6M
- IPO Year
- XNCR 2013
- IGD N/A
- Fundamental
- Price
- XNCR $8.44
- IGD $5.80
- Analyst Decision
- XNCR Buy
- IGD
- Analyst Count
- XNCR 7
- IGD 0
- Target Price
- XNCR $27.50
- IGD N/A
- AVG Volume (30 Days)
- XNCR 777.2K
- IGD 215.3K
- Earning Date
- XNCR 08-04-2025
- IGD 01-01-0001
- Dividend Yield
- XNCR N/A
- IGD 9.15%
- EPS Growth
- XNCR N/A
- IGD N/A
- EPS
- XNCR N/A
- IGD N/A
- Revenue
- XNCR $127,228,000.00
- IGD N/A
- Revenue This Year
- XNCR N/A
- IGD N/A
- Revenue Next Year
- XNCR $28.84
- IGD N/A
- P/E Ratio
- XNCR N/A
- IGD N/A
- Revenue Growth
- XNCR N/A
- IGD N/A
- 52 Week Low
- XNCR $7.16
- IGD $4.60
- 52 Week High
- XNCR $27.24
- IGD $5.26
- Technical
- Relative Strength Index (RSI)
- XNCR 47.36
- IGD 57.44
- Support Level
- XNCR $7.93
- IGD $5.73
- Resistance Level
- XNCR $9.48
- IGD $5.81
- Average True Range (ATR)
- XNCR 0.53
- IGD 0.05
- MACD
- XNCR 0.06
- IGD -0.00
- Stochastic Oscillator
- XNCR 43.29
- IGD 77.69
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.